Navigation Links
LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI
Date:8/2/2010

New Orleans, LA The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $12 million contract over seven years by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States.

"The SEER Program is the most authoritative source of information on cancer incidence and survival in the United States," said Dr. Elizabeth Fontham, Dean of the LSUHSC-NOLA School of Public Health. "Continued designation recognizes the excellence of our Louisiana Tumor Registry and confirms the exceptionally high quality of its data."

The SEER Program collects cancer incidence and survival data from 18 population-based cancer registries covering about 26% of the U.S. population. It is considered to be the standard for quality among cancer registries around the world. Quality control has been an integral part of SEER since its inception.

Cancer is a reportable disease in the State of Louisiana. Hospitals, private pathology laboratories, radiation centers and health care providers who diagnose or treat cancer are required by law to report the cancer cases to the Louisiana Tumor Registry at the LSU Health Sciences Center. The Registry includes the central office located at the LSU Health Sciences Center New Orleans and eight regional offices. Each regional registry is responsible for ascertaining all cancer cases from all possible sources in its region. The central office provides training, ensures high quality data by consolidating and editing records, and manages statewide database, as well as analyzes the data and conducts special studies.

The primary function of a cancer registry is to record the occurrence of cancer in a population. Information collected by LTR includes demographic data, tumor type, stage of disease, treatment, and survival. Information on risk factors is usually not available from the reporting sources. However, data from the registry often provides clues to be pursued in special research studies conducted by qualified scientists with external funding.

In 1995, the Louisiana Tumor Registry was transferred from the Louisiana Office of Public Health to the LSU Health Sciences Center New Orleans. Since then, the Louisiana Tumor Registry at LSU Health Sciences Center has enjoyed strong institutional support that has translated into impressive productivity. Achievements include the 1996 publication of the first comprehensive statewide monograph of Cancer Incidence in Louisiana (Volume 8 which included nine issues), Childhood Cancer in Louisiana, 1988-1996, the first comprehensive volume on childhood cancers in Louisiana, publications of Cancer in the Industrial Corridor, and multiple comprehensive statewide Cancer Incidence and Mortality monographs including the parish cancer profile. LTR data have been included in five volumes of Cancer in Five Continents published by the World Health Organization, United States Cancer Statistics published annually by NCI/CDC, Cancer Statistics Review by NCI and State Cancer Profile website.

Since 1995, data from the Louisiana Tumor Registry at the LSU Health Sciences Center have been included in the U.S. Combined Rates in Cancer in North America monographs published by the North American Association of Central Cancer Registries (NAACCR). Dr. Vivien W. Chen, Dr. Xiao Cheng Wu and other epidemiology faculty at the LSUHSC School of Public Health have been the editors of Cancer in North America since 1998. Only data meeting rigid standards for excellence and timeliness are considered for inclusion in these publications.

"This funding allows us to provide Louisiana citizens, health professionals, policy makers, and others, information about cancer incidence and mortality to better understand this devastating disease and improve health," notes Dr. Vivien W. Chen, LSUHSC Professor of Epidemiology, Director of the Louisiana Tumor Registry, and Principal Investigator on the contract. "Our data are used for prevention, early detection, treatment, and survival which, in turn, contribute to the development of national policy and efforts."


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related medicine news :

1. Key pathway in end-stage prostate cancer tumor progression blocked
2. UCLA scientists create army of tumor-fighting immune cells and watch as they attack cancer
3. Revolutionary therapy slows tumor growth in advanced breast cancer, Penn research reports
4. Optimal surgical procedure for duodenal gastrointestinal stromal tumors
5. New lung cancer drug shows dramatic results for shrinking tumors
6. Skin Appendage Tumors Seem on the Rise in U.S.
7. 3-D Brain Navigation, Minimally Invasive Surgery Combine to Help Neurosurgeon Remove Tennis Ball-Sized Tumor
8. Chopra Center Co-Founder and Mind-body Healing Pioneer David Simon, M.D. Diagnosed with Brain Tumor
9. Huge pelvi-abdominal malignant inflammatory myofibroblastic tumor
10. Tumor target suggests personalized treatment for melanoma
11. Taking aim at metastatic lung tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Guerbet announced today that it has been named a ... One of 12 suppliers to receive the ... of Premier members through exceptional local customer service and ... lower costs. "We ... customer service from Premier," says Massimo Carrara , ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
(Date:6/23/2016)... , June 23, 2016 ... "OTC Distribution in Europe 2016 Edition: The New Global Agenda ... OTC Distribution in Europe ... study that explores and tracks change. It identifies the driving ... environment for the consumer healthcare industry now and in the ...
Breaking Medicine Technology: